ABSTRACT
The association between cancer and thrombophilia has been known since 1865 since Trousseau described it. However in the last three decades an increased interest has been raised on this issue related to several molecular and condition that are involved in the daily management of oncological patients. This brief review has been focused on molecular conditions underlying cancer acquired thrombophilia then to further clinical aspects inducing thrombophilia in oncological patients such as surgery, chemotherapy, concomitant medical illness and inherited thrombophilia.
Subject(s)
Neoplasms/complications , Thromboembolism/diagnosis , Thrombophilia/complications , Thrombophilia/genetics , Venous Thrombosis/diagnosis , Blood Coagulation Tests , Humans , Neoplasms/genetics , Patients , Thromboembolism/etiology , Thromboembolism/surgery , Venous Thrombosis/etiology , Venous Thrombosis/surgeryABSTRACT
OBJECTIVES: To investigate the intima-media thickness of the common carotid arteries (IMT-CCA) in patients with Rheumatoid Arthritis (RA), and its relationships with classical atherosclerosis risk factors and disease features i.e. duration, activity and disability. METHODS: 48 RA patients (35 F, 13 M; age ed 26-69 years median 55; disease duration 1-18 years, median 8), and 22 controls (16 F, 6 M; age 28-66, median 50) matched for classical atherosclerosis risk factors, i.e. age, sex, smoking, blood pressure, body mass index, diabetes, familiarity, and for postmenopausal status, were studied. IMT and plaques were measured in the left and right common carotid arteries. Serum total cholesterol, triglyceride, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, apoliporotein AI, apolipoprotein B, and rheumatoid factor were determined in patients and controls. The DAS28, the HAQ-DI and disease duration were considered as clinical parameters reflecting disease status. RESULTS: The IMT-CCA (mean +/- SD) was significantly greater in the 48 RA patients than in the 22 controls subjects (1.00+/-0.25 vs. 0.78+/-0.21; p=0.0007). In the 70 subjects investigated CCA-IMT resulted to be significantly correlated with diastolic blood pressure, body mass index, triglyceride and RA status. In the 48 RA patients no correlation was detected with either disease duration or activity or disability. CONCLUSION: our study confirms an increased IMT in RA patients without any clinically evident manifestation of cardiovascular disease. It supports the existence of subclinical atherosclerosis in RA.
Subject(s)
Arteriosclerosis/etiology , Arthritis, Rheumatoid/complications , Carotid Artery, Common/diagnostic imaging , Tunica Intima/diagnostic imaging , Tunica Media/diagnostic imaging , Adult , Aged , Arteriosclerosis/diagnostic imaging , Arthritis, Rheumatoid/blood , Arthritis, Rheumatoid/diagnosis , Arthritis, Rheumatoid/diagnostic imaging , Body Mass Index , Cholesterol/blood , Data Interpretation, Statistical , Diastole , Female , Humans , Male , Middle Aged , Rheumatoid Factor/blood , Risk Factors , Time Factors , Triglycerides/blood , UltrasonographyABSTRACT
BACKGROUND: Cancer is one of the most common acquired causes of venous thromboembolism. AIM: To evaluate haemostasis disorders in patients with non-metastatic gastric cancer. PATIENTS AND METHODS: We studied 11 patients with non-metastatic gastric cancer (9 males and 2 females, median age 54 years) and 20 healthy subjects (15 males and 5 females, median age 48 years) control. We measured prothrombin time, activated partial thromboplastin time, coagulation time, clot lysis time, fibrinogen, clotting factors (II, VII, VIII, IX, X), C protein, S protein, AT III, activated protein C resistance, prothrombin 1+2 fragment, tissue plasminogen activator and D-Dimer in all subjects. RESULTS: Fibrinogen plasma levels were significantly higher in patients with non-metastatic gastric cancer than in control group (505+/-24 mg/dl vs 336+/-30 mg/dl, p<0.001). We also found a significant increase in prothrombin 1+2 fragment plasma concentration compared with controls (3.8+/-0.6 nM vs 0.83+/-0.09 nM, p<0.001). Plasma D-dimer levels were 20-fold higher in patients with non-metastatic gastric cancer compared with controls (9.57+/-0.4 ng/dl vs 0.4+/-0.05 ng/dl, p<0.001). Also tissue plasminogen activator was significantly higher in gastric cancer patients than in controls (20.8+/-2.32 ng/ml vs 9.1+/-1.37 ng/ml, p<0.01). Finally clot lysis time was significantly accelerated in gastric cancer patients compared with control subjects (81+/-37 min vs 233+/-74 min, p<0.01). CONCLUSIONS: Patients with non-metastatic gastric cancer are at risk for thrombotic events due to the combined increase in fibrinogen plasma levels and thrombin formation.
Subject(s)
Fibrinogen/analysis , Stomach Neoplasms/blood , Thrombin/analysis , Thromboembolism/blood , Activated Protein C Resistance , Case-Control Studies , Female , Fibrin Fibrinogen Degradation Products/analysis , Fibrinolysis , Hemostasis/physiology , Humans , Male , Middle Aged , Partial Thromboplastin Time , Prothrombin Time , Stomach Neoplasms/complications , Thromboembolism/etiology , Tissue Plasminogen Activator/analysisABSTRACT
The case of autoimmune chronic active hepatitis in a 57-year-old female is reported. Onset was signalled by an abrupt and dramatic thrombocytopenia, which was also the only laboratory parameter able to monitor treatment and progression of the disease. It is concluded that thrombocytopenia together with the presence of antiplatelet-antibodies might be useful markers to monitor the treatment and evolution of the disease.